To amend title III of the Public Health Service Act to temporarily limit the use of rebates under the 340B Program.
Latest action (9 Oct 2026): Introduced
What this bill does
This bill, H.R. 10770, has been introduced in the House of Representatives by Representative Robert Bresnahan. Its stated purpose, according to its title, is to amend a section of federal law called the Public Health Service Act. Specifically, it aims to place a temporary limit on how rebates can be used within a program known as the 340B Program.
The 340B Program is a federal program that allows certain healthcare providers to purchase outpatient drugs at reduced prices. The bill's title suggests it would affect entities participating in this program and potentially how they manage the savings they receive from drug rebates. The full details of the bill's provisions, including the exact nature of the temporary limits and their duration, are not yet publicly available as the official text has not been published.
As of October 9, 2026, H.R. 10770 is in its initial stage of the legislative process, having been introduced. For the bill to potentially become law, it would need to pass through various committees in the House of Representatives, be voted on by the full House, and then go through a similar process in the Senate. If passed by both chambers in identical form, it would then be sent to the President for signature or veto.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
This bill is in the first stage of the legislative process. It was introduced into Congress on October 9, 2026. It will typically be considered by committee next before it is possibly sent on to the House or Senate as a whole.
Common questions
- What does H.R. 10770 do?
- This bill, H.R. 10770, has been introduced in the House of Representatives by Representative Robert Bresnahan. Its stated purpose, according to its title, is to amend a section of federal law called the Public Health Service Act. Specifically, it aims to place a temporary limit on how rebates can be used within a program known as the 340B Program. The 340B Program is a federal program that allows certain healthcare providers to purchase outpatient drugs at reduced prices. The bill's title suggests it would affect entities participating in this program and potentially how they manage the savings they receive from drug rebates. The full details of the bill's provisions, including the exact nature of the temporary limits and their duration, are not yet publicly available as the official text has not been published. As of October 9, 2026, H.R. 10770 is in its initial stage of the legislative process, having been introduced. For the bill to potentially become law, it would need to pass through various committees in the House of Representatives, be voted on by the full House, and then go through a similar process in the Senate. If passed by both chambers in identical form, it would then be sent to the President for signature or veto.
- Has H.R. 10770 become law?
- Not yet. As of 9 Oct 2026, H.R. 10770 is introduced.
- Who sponsored H.R. 10770?
- H.R. 10770 was sponsored by Rep. Robert Bresnahan [R-PA8] (Republican-PA), with 0 cosponsors.
- What's the latest action on H.R. 10770?
- Introduced (9 Oct 2026).
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.